Anti-IL-6 antibodies for the treatment of arthritis
US8992920B2 · kind B2 · utility
25Cited by
98References
61Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 23, 2011 |
| Grant date | Mar 31, 2015 |
| Priority date | — |
| Expiry date | Nov 23, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.